JANE STREET GROUP, LLC - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 45 filers reported holding REDHILL BIOPHARMA LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q4 2022$2,015
-77.6%
14,364
+33.4%
0.00%
Q2 2022$9,000
-90.9%
10,770
-72.4%
0.00%
Q1 2022$99,000
-56.8%
39,075
-56.7%
0.00%
Q4 2021$229,000
-78.1%
90,276
-60.5%
0.00%
Q3 2021$1,044,000
+635.2%
228,399
+1002.0%
0.00%
Q2 2021$142,000
+49.5%
20,725
+59.4%
0.00%
Q1 2021$95,0000.0%13,000
-38.2%
0.00%
Q1 2020$95,000
-75.3%
21,036
-64.6%
0.00%
-100.0%
Q2 2019$384,000
+39.1%
59,405
+108.1%
0.00%0.0%
Q1 2017$276,00028,5480.00%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q3 2022
NameSharesValueWeighting ↓
Broadfin Capital, LLC 717,203$9,962,0000.89%
BANK HAPOALIM BM 147,504$2,049,0000.48%
MENORA MIVTACHIM HOLDINGS LTD. 246,000$3,417,0000.19%
Family Management Corp 16,500$229,0000.13%
Orbimed Advisors 564,900$7,846,0000.09%
SABBY MANAGEMENT, LLC 63,800$888,0000.03%
INGALLS & SNYDER LLC 41,550$577,0000.03%
Candriam S.C.A. 71,267$992,0000.02%
MONETARY MANAGEMENT GROUP INC 3,000$42,0000.02%
D.A. DAVIDSON & CO. 26,500$368,0000.01%
View complete list of REDHILL BIOPHARMA LTD shareholders